Search Results

Liver Cirrhosis: Causes, Diagnosis and Treatment

• Authors : Michelli, Miranda L.

Subjects: Liver--CirrhosisMEDICAL / Hepatology

Record details

Health-related quality of life in patients with liver cirrhosis following adjunctive nurse-based care versus standard medical care: a pragmatic, multicentre, randomised controlled study

• Authors : Hjorth, Maria; Sjöberg, Daniel; Svanberg, Anncarin

Subjects: CLINICAL TRIALS; LIVER CIRRHOSIS; QUALITY OF LIFE

• Source: BMJ Open Gastroenterology. 12(1)

Record details

Characterising spontaneous bacterial peritonitis in liver cirrhosis and hepatocellular carcinoma in southwestern Nigeria

• Authors : G. Adeyeye, Abosede; T. Adeyemo, Adeyemi; O. Adeyeye, Victor

Subjects: Nigeria; spontaneous bacterial peritonitis; liver cirrhosis and HCC

• Source: Ghana Medical Journal; Vol. 59 No. 2 (2025); 52-59

Record details

The Role of Magnesium in Liver Cirrhosis

• Authors : Weiye Zeng; Xudan Wang; He Qi

Subjects: liver cirrhosis; oxidative stress; inflammatory response

• Source: Portal Hypertension & Cirrhosis, Vol 4, Iss 2, Pp 120-133 (2025)

Record details

From signaling pathways to clinical trials: mesenchymal stem cells as multimodal regenerative architects in liver cirrhosis therapy.

• Authors : Bozorgi V; Clinical Research Development Center, Qom University of Medical Sciences, Qom, Iran.; Qom Gastroenterology and Hepatology Disease Research Center, Qom University of Medical Sciences, Qom, Iran.

Subjects: Liver Cirrhosis*/Liver Cirrhosis*/Liver Cirrhosis*/therapy ; Liver Cirrhosis*/Liver Cirrhosis*/Liver Cirrhosis*/pathology ; Mesenchymal Stem Cells*/Mesenchymal Stem Cells*/Mesenchymal Stem Cells*/metabolism

• Source: Stem cell research & therapy [Stem Cell Res Ther] 2025 Aug 05; Vol. 16 (1), pp. 421. Date of Electronic Publication: 2025 Aug 05.Publisher: BioMed Central Country of Publication: England NLM ID: 101527581 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-6512

Record details

Prognostic value of neutrophil-to-lymphocyte ratio in septic patients with liver cirrhosis: a cohort study.

• Authors : Song F; Intensive Care Unit, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, 26 Shengli Street, Wuhan, 430014, People's Republic of China.; Wu XL

Subjects: Liver Cirrhosis*/Liver Cirrhosis*/Liver Cirrhosis*/mortality ; Liver Cirrhosis*/Liver Cirrhosis*/Liver Cirrhosis*/blood ; Liver Cirrhosis*/Liver Cirrhosis*/Liver Cirrhosis*/complications

• Source: BMC gastroenterology [BMC Gastroenterol] 2025 Aug 01; Vol. 25 (1), pp. 549. Date of Electronic Publication: 2025 Aug 01.Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X

Record details

Histological Improvement of Hepatic Fibrosis of Decompensated Liver Cirrhosis after Prednisolone and Azathioprine Treatment in a Patient with Autoimmune Hepatitis.

• Authors : Suzuki H; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine.; Amano K

Subjects: Hepatitis, Autoimmune*/Hepatitis, Autoimmune*/Hepatitis, Autoimmune*/drug therapy ; Hepatitis, Autoimmune*/Hepatitis, Autoimmune*/Hepatitis, Autoimmune*/complications ; Hepatitis, Autoimmune*/Hepatitis, Autoimmune*/Hepatitis, Autoimmune*/diagnosis

• Source: The Kurume medical journal [Kurume Med J] 2025 Aug 01; Vol. 71 (1.2), pp. 69-74. Date of Electronic Publication: 2024 Nov 27.Publisher: Kurume Univ., School of Medicine Country of Publication: Japan NLM ID: 2985210R Publication Model: Print-Electronic Cited Medium: Internet

Record details

Severe Hypocalcemia During JAK1/2 Inhibitor Therapy for Myelofibrosis in a Patient with Liver Cirrhosis.

• Authors : Kurumazaki M; Department of Internal Medicine 1, Shimane University Faculty of Medicine, Japan.; Ogawa N

Subjects: Primary Myelofibrosis*/Primary Myelofibrosis*/Primary Myelofibrosis*/drug therapy ; Primary Myelofibrosis*/Primary Myelofibrosis*/Primary Myelofibrosis*/complications ; Hypocalcemia*/Hypocalcemia*/Hypocalcemia*/chemically induced

• Source: Internal medicine (Tokyo, Japan) [Intern Med] 2025 Aug 01; Vol. 64 (15), pp. 2338-2343. Date of Electronic Publication: 2025 Jan 15.Publisher: Japanese Society of Internal Medicine Country of Publication: Japan NLM ID: 9204241 Publication Model: Print-Electronic Cited Medium:

Record details

Identification of CTSK as a TLR-related critical biomarker in liver cirrhosis via integrative bioinformatics and pathological characterization.

• Authors : Wang J; Department of Gastroenterology and Hepatology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.; Li N

Subjects: Liver Cirrhosis*/Liver Cirrhosis*/Liver Cirrhosis*/genetics ; Liver Cirrhosis*/Liver Cirrhosis*/Liver Cirrhosis*/pathology ; Liver Cirrhosis*/Liver Cirrhosis*/Liver Cirrhosis*/metabolism

• Source: Scientific reports [Sci Rep] 2025 Jul 17; Vol. 15 (1), pp. 25895. Date of Electronic Publication: 2025 Jul 17.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Integrated analyses to explore the mechanism of Gancao Renshen Zhixue Decoction in treating liver cirrhosis.

• Authors : Pan J; Department of Pharmacy , Deqing Hospital of Traditional Chinese Medicine, No.383 Qunyi Street, Wukang Town, Deqing County, Huzhou, 313200, Zhejiang, China. .

Subjects: Drugs, Chinese Herbal*/Drugs, Chinese Herbal*/Drugs, Chinese Herbal*/pharmacology ; Drugs, Chinese Herbal*/Drugs, Chinese Herbal*/Drugs, Chinese Herbal*/therapeutic use ; Drugs, Chinese Herbal*/Drugs, Chinese Herbal*/Drugs, Chinese Herbal*/chemistry

• Source: Scientific reports [Sci Rep] 2025 Jul 02; Vol. 15 (1), pp. 23496. Date of Electronic Publication: 2025 Jul 02.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details